Cite
[Usefulness of 201Tl myocardial scintigraphy after dipyridamole infusion in patients with atherosclerotic vascular disease]
MLA
T, Toyama, et al. “[Usefulness of 201Tl Myocardial Scintigraphy after Dipyridamole Infusion in Patients with Atherosclerotic Vascular Disease].” Kaku Igaku. The Japanese Journal of Nuclear Medicine, vol. 29, no. 3, Mar. 1992. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........7965adb8c499e99c87e2bf36d936521f&authtype=sso&custid=ns315887.
APA
T, T., T, N., T, U., T, S., K, H., S, H., Y, H., T, K., A, I., & H, N. (1992). [Usefulness of 201Tl myocardial scintigraphy after dipyridamole infusion in patients with atherosclerotic vascular disease]. Kaku Igaku. The Japanese Journal of Nuclear Medicine, 29(3).
Chicago
T, Toyama, Nishimura T, Uehara T, Shimonagata T, Hayashida K, Hamada S, Hirose Y, Kaminaga T, Ito A, and Nonogi H. 1992. “[Usefulness of 201Tl Myocardial Scintigraphy after Dipyridamole Infusion in Patients with Atherosclerotic Vascular Disease].” Kaku Igaku. The Japanese Journal of Nuclear Medicine 29 (3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........7965adb8c499e99c87e2bf36d936521f&authtype=sso&custid=ns315887.